21) Biocon - Biosimilars Coming of Age FY26: Revenue 16,927 Cr (+13%) | Biosimilars 10,431 Cr (+16%) | Q4 Biosimilar EBITDA Margin 26% Biocons biosimilar franchise has reached a scale and profitability that vindicates years of investment
8OHdG as a marker for Huntington disease progression
49 These cell contents, also known as damage-associated molecular patterns (DAMPs), may bind to and activate Toll-like receptors in macrophages, promote the formation of inflammasome complexes, and induce the release of pro-inflammatory cytokines
Yet, culturally, people often view supplements as benign additions to their diets, rather than remedies that can be both effective and intense
Your healthcare team can review your treatment plan, adjust medications if necessary, and provide mental health support such as NHS Talking Therapies
T he study predicted that 3 to 10 percent of children in the United States will have autism by 2060, and that the increased prevalence will cost the nation $5.5 trillion a year